[go: up one dir, main page]

PE20030035A1 - Composiciones y metodos para la deteccion de biomarcadores relacionados con la enfermedad cardiovascular - Google Patents

Composiciones y metodos para la deteccion de biomarcadores relacionados con la enfermedad cardiovascular

Info

Publication number
PE20030035A1
PE20030035A1 PE2001000827A PE2001000827A PE20030035A1 PE 20030035 A1 PE20030035 A1 PE 20030035A1 PE 2001000827 A PE2001000827 A PE 2001000827A PE 2001000827 A PE2001000827 A PE 2001000827A PE 20030035 A1 PE20030035 A1 PE 20030035A1
Authority
PE
Peru
Prior art keywords
detection
cardiovascular disease
compositions
methods
biomarkers related
Prior art date
Application number
PE2001000827A
Other languages
English (en)
Inventor
Mario Hugo Genero
Elizabeth Edit Ojeda
Original Assignee
Genomics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomics Ltd filed Critical Genomics Ltd
Publication of PE20030035A1 publication Critical patent/PE20030035A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

SE REFIERE A UN DISPOSITIVO QUE TIENE UNA SUPERFICIE RELATIVAMENTE PLANA, SOBRE EL CUAL SE ORDENAN UNA PLURALIDAD DE MUESTRAS DE TEJIDO CARDIOVASCULAR HUMANO DE POR LO MENOS UN DONANTE, DONDE DICHA PLURALIDAD COMPRENDE UNA PRIMERA MUESTRA DE UNA PRIMERA ETAPA DE LA ENFERMEDAD Y UNA SEGUNDA MUESTRA DE UNA SEGUNDA ETAPA DE LA ENFERMEDAD. SE REFIERE TAMBIEN A UN METODO QUE COMPRENDE: 1)PROVEER EL DISPOSITIVO DESCRITO ANTERIORMENTE; Y, 2)TRATAMIENTO DE LA PLURALIDAD DE MUESTRAS DE TEJIDO EN CONDICIONES TALES QUE PERMITEN LA DETECCION DE UN BIOMARCADOR RELACIONADO CON LA ENFERMEDAD CARDIOVASCULAR
PE2001000827A 2001-06-05 2001-08-20 Composiciones y metodos para la deteccion de biomarcadores relacionados con la enfermedad cardiovascular PE20030035A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2001/002464 WO2002099429A1 (en) 2001-06-05 2001-06-05 Compositions and methods for the detection of biomarkers associated with cardiovascular disease

Publications (1)

Publication Number Publication Date
PE20030035A1 true PE20030035A1 (es) 2003-01-31

Family

ID=9907866

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000827A PE20030035A1 (es) 2001-06-05 2001-08-20 Composiciones y metodos para la deteccion de biomarcadores relacionados con la enfermedad cardiovascular

Country Status (8)

Country Link
US (1) US20040215087A1 (es)
EP (1) EP1393074A1 (es)
AR (1) AR030643A1 (es)
CA (1) CA2445991A1 (es)
PA (1) PA8526001A1 (es)
PE (1) PE20030035A1 (es)
SV (1) SV2003000607A (es)
WO (1) WO2002099429A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7885709B2 (en) * 2001-08-31 2011-02-08 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation for treating disorders
US7904176B2 (en) 2006-09-07 2011-03-08 Bio Control Medical (B.C.M.) Ltd. Techniques for reducing pain associated with nerve stimulation
US8571653B2 (en) 2001-08-31 2013-10-29 Bio Control Medical (B.C.M.) Ltd. Nerve stimulation techniques
US20080119898A1 (en) * 2005-09-22 2008-05-22 Biocontrol Medical Ltd. Nitric oxide synthase-affecting parasympathetic stimulation
DE10149345B4 (de) * 2001-10-06 2007-11-15 Leica Mikrosysteme Gmbh Vorrichtung zur schnellen Gewebepräparation für histologische Untersuchungen
JP5309026B2 (ja) * 2006-08-04 2013-10-09 メディツィニッシュ ホホシュール ハノーバー Ｇｄｆ−１５に基づく心臓インターベンションの危険性を評価するための手段および方法
EP2156370B1 (en) 2007-05-14 2011-10-12 Historx, Inc. Compartment segregation by pixel characterization using image data clustering
CA2690633C (en) 2007-06-15 2015-08-04 Historx, Inc. Method and system for standardizing microscope instruments
CA2604317C (en) 2007-08-06 2017-02-28 Historx, Inc. Methods and system for validating sample images for quantitative immunoassays
CA2596204C (en) 2007-08-07 2019-02-26 Historx, Inc. Method and system for determining an optimal dilution of a reagent
US7978258B2 (en) 2007-08-31 2011-07-12 Historx, Inc. Automatic exposure time selection for imaging tissue
WO2009157945A1 (en) * 2008-06-27 2009-12-30 Alan Gevins Determination of treatment results prior to treatment or after few treatment events
CA2737116C (en) 2008-09-16 2019-01-15 Historx, Inc. Reproducible quantification of biomarker expression
WO2015130792A1 (en) * 2014-02-25 2015-09-03 Rutgers, The State University Of New Jersey Methods for the identification and quantification of pathogens using imaging and microscopy techniques
US11143659B2 (en) 2015-01-27 2021-10-12 Arterez, Inc. Biomarkers of vascular disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2149617A1 (en) * 1994-06-13 1995-12-14 Alexander Krichevsky Differential immunocytochemical diagnosis of cancer using antibodies or antisera against hcg.beta.
WO2000014281A2 (en) * 1998-08-21 2000-03-16 Naxcor Assays using crosslinkable immobilized nucleic acids
EP1131470A4 (en) * 1998-10-28 2004-11-10 Vysis Inc CELLULAR NETWORKS AND METHODS FOR DETECTION AND USE OF GENETIC DISORDER MARKERS
EP1135680A4 (en) * 1999-09-24 2004-12-15 Ventana Med Syst Inc HIGH-PERFORMANCE SYSTEM FOR EVALUATING THE CLINICAL BENEFIT OF TARGET MOLECULAR MOLECULES IN TISSUE SAMPLES

Also Published As

Publication number Publication date
WO2002099429A1 (en) 2002-12-12
CA2445991A1 (en) 2002-12-12
SV2003000607A (es) 2003-11-04
AR030643A1 (es) 2003-08-27
EP1393074A1 (en) 2004-03-03
US20040215087A1 (en) 2004-10-28
PA8526001A1 (es) 2003-01-24

Similar Documents

Publication Publication Date Title
PE20030035A1 (es) Composiciones y metodos para la deteccion de biomarcadores relacionados con la enfermedad cardiovascular
CL2021003221A1 (es) (divisional de solicitud 400-2021) métodos para reducir la necesidad de revascularización arterial periférica en un sujeto tratado con estatinas.
EP1668116A4 (en) METHOD FOR IMPROVING EMBRYOVIABILITY
EP2402437A3 (en) Protease screening methods and proteases identified thereby
AR039102A1 (es) Chip de circuitos integrados para ensayos biologicos
AR046832A1 (es) Ensayos de rastreo y metodos de tratamiento de tumores
BRPI0511977A (pt) dispositivos e métodos para remover agentes alvo de uma amostra
EP2420837A3 (en) An in vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
BRPI0617788A2 (pt) processos isolados estaticamente verificáveis com comunicação interprocessos
AR013671A1 (es) Dispositivo de ensayo para la determinacion de substancias a analizar en un producto dietario liquido, procedimiento para la deteccion de substancias a analizar en un producto dietario y kit de ensayo que comprende dicho dispositivo
BRPI0412377A (pt) métodos baseados em qtl denominados "mapeamento as-you-go"
WO2002056749A3 (en) Diagnostic and monitoring methods for cancer
DE60225520D1 (de) Kreuzfahrtschiff grosser Breite
ES2528321T3 (es) Detección de a-fucosilación en anticuerpos
CL2007003800A1 (es) Metodo para el tratamiento de la hipertension ocular que comprende un agente de molecula pequena que interactua con un gen que codifica para la proteina amiloide serica a (saa).
BR0200178B1 (pt) processo e dispositivo para a evacuação de passageiros de elevador.
ATE385741T1 (de) Gewebe- und flüssigkeitsentnahmevorrichtung
WO2003027895A3 (en) Character string conversion
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
ITMI20031819A1 (it) Dispositivo per la lavorazione di pezzi sostanzialmente piatti.
FI20031370A0 (fi) Automaattinen hemoglobiinin määritysmenetelmä vastasyntyneiden seulontaan
ITPI20000027A0 (it) Metodo ed apparecchiatura per apertura, posizionamento e caricamento su forme di calzini, gambaletti e simili.
BRPI0514672A (pt) polipeptìdeos de fusobacterium e métodos de uso
AR050213A1 (es) Ensayo de diagnostico ileitis
BR0300368B1 (pt) máscara, dispositivo e método para depositar reagentes sobre um suporte analítico para amostras biológicas, método para detectar os constituintes de uma ou mais amostras biológicas por imunofixação, e, kit.

Legal Events

Date Code Title Description
FC Refusal